Patents by Inventor Sonja KRÖSSER

Sonja KRÖSSER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Opthalmic compositions comprising F6H8
    Patent number: 11896559
    Abstract: The present disclosure provides methods of treatment using ophthalmic compositions comprising semifluorinated alkanes for keratoconjunctivitis sicca and/or Meibomian gland dysfunction, which methods provide for the enrichment of an ophthalmic tissue in the semifluorinated alkane, and optionally methods of delayed release of the semifluorinated alkane from the enriched ophthalmic tissue to the surface of the cornea and/or conjunctiva, and/or to the Meibomian gland.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: February 13, 2024
    Assignee: NOVALIQ GMBH
    Inventors: Bernhard Günther, Frank Löscher, Hartmut Voss, Sonja Krösser, Kirsten Eickhoff, Daniela Willen, Markus Beier, Thomas Schlüter
  • Pharmaceutical compositions for use in the therapy of blepharitis
    Patent number: 11684589
    Abstract: The present invention provides a pharmaceutical composition comprising 1-perfluorohexyl-octane (F6H8) for use in the therapy, treatment, prevention or amelioration of anterior or posterior blepharitis, preferably posterior blepharitis or symptoms associated therewith. Furthermore, the present invention provides a pharmaceutical kit for the therapy of anterior or posterior blepharitis or symptoms associated therewith.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: June 27, 2023
    Assignee: NOVALIQ GMBH
    Inventors: Bernhard Günther, Frank Löscher, Sonja Krösser
  • OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE
    Publication number: 20230043641
    Abstract: The invention provides pharmaceutical compositions comprising about 0.05 to 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane for use in the topical treatment of dry eye disease and provides for dosing and treatment methods thereof. The invention further provides kits comprising such compositions.
    Type: Application
    Filed: September 19, 2022
    Publication date: February 9, 2023
    Applicant: NOVALIQ GMBH
    Inventors: Markus BEIER, Jörg HAISSER, Alice MEIDES, Sonja KRÖSSER, Hartmut VOSS, Frank LÖSCHER, Bernhard GÜNTHER
  • Ophthalmic composition for treatment of dry eye disease
    Patent number: 11413323
    Abstract: The invention provides ophthalmic compositions comprising about 0.1 % (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease. The invention further provides kits comprising such compositions for the same use.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: August 16, 2022
    Assignee: NOVALIQ GMBH
    Inventors: Chiara Silvana Leo, Sonja Krösser, Thomas Schlüter, Alice Meides
  • OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE
    Publication number: 20220226427
    Abstract: The invention provides ophthalmic compositions comprising about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease and provides for treatment methods thereof. The invention further provides kits comprising such compositions.
    Type: Application
    Filed: April 1, 2022
    Publication date: July 21, 2022
    Inventors: Chiara Silvana LEO, Sonja KRÖSSER, Thomas SCHLÜTER, Alice MEIDES
  • OPHTHALMIC COMPOSITIONS FOR TREATMENT OF OCULAR SURFACE DAMAGE AND SYMPTOMS OF DRYNESS
    Publication number: 20210346313
    Abstract: The present disclosure provides methods of treatment using ophthalmic compositions, comprising 1-perfluorohexyloctane, which are useful in the treatment of ocular surface damage of the cornea and/or symptoms of dryness.
    Type: Application
    Filed: September 20, 2019
    Publication date: November 11, 2021
    Inventors: Markus BEIER, Daniela WILLEN, Sonja KRÖSSER, Thomas SCHLÜTER
  • OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE
    Publication number: 20210236591
    Abstract: The invention provides ophthalmic compositions comprising about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease. The invention further provides kits comprising such compositions for the same use.
    Type: Application
    Filed: April 12, 2021
    Publication date: August 5, 2021
    Inventors: Chiara Silvana LEO, Sonja KRÖSSER, Thomas SCHLÜTER, Alice MEIDES
  • PHARMACEUTICAL COMPOSITIONS COMPRISING TIMOLOL
    Publication number: 20210121471
    Abstract: The present invention relates to pharmaceutical composition comprising the beta 1(?1)-receptor blocker timolol and a liquid vehicle comprising a semifluorinated alkane. The pharmaceutical composition of the present invention may be useful for topical administration, for example ophthalmic topical administration and for use in the treatment of glaucoma, increased intraocular pressure, ocular hypertension and/or a symptom associated therewith.
    Type: Application
    Filed: March 25, 2019
    Publication date: April 29, 2021
    Inventors: Frank LÖSCHER, Sonja KRÖSSER, Diana STREHL, Bernhard HAUPTMEIER, Kirsten EICKHOFF
  • OPTHALMIC COMPOSITIONS COMPRISING F6H8
    Publication number: 20200268682
    Abstract: The present disclosure provides methods of treatment using ophthalmic compositions comprising semifluorinated alkanes for keratoconjunctivitis sicca and/or Meibomian gland dysfunction, which methods provide for the enrichment of an ophthalmic tissue in the semifluorinated alkane, and optionally methods of delayed release of the semifluorinated alkane from the enriched ophthalmic tissue to the surface of the cornea and/or conjunctiva, and/or to the Meibomian gland.
    Type: Application
    Filed: October 3, 2018
    Publication date: August 27, 2020
    Inventors: Bernhard GÜNTHER, Frank LÖSCHER, Hartmut VOSS, Sonja KRÖSSER, Kirsten EICKHOFF, Daniela WILLEN, Markus BEIER, Thomas SCHLÜTER
  • COMPOSITIONS COMPRISING A CANNABINOID RECEPTOR BINDING LIGAND
    Publication number: 20190343793
    Abstract: The present invention provides a pharmaceutical composition comprising: a) a therapeutically effective amount of at least one cannabinoid receptor binding ligand, and b) a liquid vehicle comprising at least one semifluorinated alkane; as well as the use of such pharmaceutical compositions as a medicament.
    Type: Application
    Filed: September 27, 2017
    Publication date: November 14, 2019
    Inventors: Bernhard GÜNTHER, Frank LÖSCHER, Sonja KRÖSSER, Philipp STEVEN
  • PHARMACEUTICAL COMPOSITIONS FOR USE IN THE THERAPY OF BLEPHARITIS
    Publication number: 20190274970
    Abstract: The present invention provides a pharmaceutical composition comprising 1-perfluorohexyl-octane (F6H8) for use in the therapy, treatment, prevention or amelioration of anterior or posterior blepharitis, preferably posterior blepharitis or symptoms associated therewith. Furthermore, the present invention provides a pharmaceutical kit for the therapy of anterior or posterior blepharitis or symptoms associated therewith.
    Type: Application
    Filed: September 20, 2017
    Publication date: September 12, 2019
    Inventors: Bernhard GÜNTHER, Frank LÖSCHER, Sonja KRÖSSER
  • OPHTHALMIC COMPOSITION FOR TREATMENT OF DRY EYE DISEASE
    Publication number: 20180360908
    Abstract: The invention provides pharmaceutical compositions comprising about 0.05 to 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane for use in the topical treatment of dry eye disease and provides for dosing and treatment methods thereof. The invention further provides kits comprising such compositions.
    Type: Application
    Filed: August 22, 2018
    Publication date: December 20, 2018
    Inventors: Markus BEIER, Jörg HAISSER, Alice MEIDES, Sonja KRÖSSER, Hartmut VOSS, Frank LÖSCHER, Bernhard GÜNTHER